Tender For Supply Of Trivalent Seasonal Influenza Vaccine (Siv) For Haj Session 2027
Tender Overview
Project Description
Tender for Supply Of Trivalent Seasonal Influenza Vaccine (Siv) For Haj Session 2027 , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2027 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Missouri/11/2025 (H1n1)Pdm09-Like Virus; • An A/Darwin/1454/2025 (H3n2)-Like Virus; And • A B/Tokyo/Eis13-175/2025 (B/Victoria Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2027 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Missouri/11/2025 (H1n1)Pdm09-Like Virus; • An A/Darwin/1454/2025 (H3n2)-Like Virus; And • A B/Tokyo/Eis13-175/2025 (B/Victoria Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2027 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Missouri/11/2025 (H1n1) Pdm09-Like Virus; • An A/Darwin/1454/2025 (H3n2)-Like Virus; And • A B/Tokyo/Eis13-175/2025 (B/Victoria Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2027 Influenza Season (Nh) Contain The Following: Cell Culture-, Recombinant Protein - Or Nucleic Acid Based Vaccines • An A/Missouri/11/2025 (H1n1) Pdm09-Like Virus; • An A/Darwin/1415/2025 (H3n2)-Like Virus; And • A B/Pennsylvania/14/2025 (B/Victoria Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2027 Influenza Season (Nh) Contain The Following: Cell- Or Recombinant Protein - Or Nucleic Acid Based Vaccines • An A/Missouri/11/2025 (H1n1)Pdm09-Like Virus; • An A/Darwin/1415/2025 (H3n2)-Like Virus; And • A B/Pennsylvania/14/2025 (B/Victoria Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2027 Influenza Season (Nh) Contain The Following: Cell Culture-, Recombinant Protein - Or Nucleic Acid Based Vaccines • An A/Missouri/11/2025 (H1n1) Pdm09-Like Virus; • An A/Darwin/1415/2025 (H3n2)-Like Virus; And • A B/Pennsylvania/14/2025 (B/Victoria Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Available At The Time Of Delivery. Minimum Shelf Life: 12 Months
BOQ
| Sl. No. | Item Description |
| 1 | Seasonal Influenza Vaccine (Trivalent)(For Adults)Specification:As per the WHO recommendations the Trivalent vaccines for use in the 2027 influenza season (NH) contain the following: Egg-based Vaccines• an A/Missouri/11/2025 (H1N1)pdm09-like virus;• an A/Darwin/1454/2025 (H3N2)-like virus; and• a B/Tokyo/EIS13-175/2025 (B/Victoria lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.Minimum Shelf Life: 12 Months |
| 2 | Seasonal Influenza Vaccine (Trivalent)(For Adults)Specification:As per the WHO recommendations the Trivalent vaccines for use in the 2027 influenza season (NH) contain the following: Egg-based Vaccines• an A/Missouri/11/2025 (H1N1)pdm09-like virus;• an A/Darwin/1454/2025 (H3N2)-like virus; and• a B/Tokyo/EIS13-175/2025 (B/Victoria lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.Minimum Shelf Life: 12 Months |
| 3 | Seasonal Influenza Vaccine (Trivalent)(For Adults)Specification:As per the WHO recommendations the Trivalent vaccines for use in the 2027 influenza season (NH) contain the following: Egg-based Vaccines• an A/Missouri/11/2025 (H1N1) pdm09-like virus;• an A/Darwin/1454/2025 (H3N2)-like virus; and• a B/Tokyo/EIS13-175/2025 (B/Victoria lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.Minimum Shelf Life: 12 Months |
| 4 | Seasonal Influenza Vaccine (Trivalent)(For Adults)Specification:As per the WHO recommendations the Trivalent vaccines for use in the 2027 influenza season (NH) contain the following: Cell culture-, recombinant protein - or Nucleic Acid based vaccines• an A/Missouri/11/2025 (H1N1) pdm09-like virus;• an A/Darwin/1415/2025 (H3N2)-like virus; and • a B/Pennsylvania/14/2025 (B/Victoria lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.Minimum Shelf Life: 12 Months |
| 5 | Seasonal Influenza Vaccine (Trivalent)(For Adults)Specification:As per the WHO recommendations the Trivalent vaccines for use in the 2027 influenza season (NH) contain the following: Cell- or recombinant protein - or Nucleic Acid based vaccines• an A/Missouri/11/2025 (H1N1)pdm09-like virus;• an A/Darwin/1415/2025 (H3N2)-like virus; and • a B/Pennsylvania/14/2025 (B/Victoria lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.Minimum Shelf Life: 12 Months |
| 6 | Seasonal Influenza Vaccine (Trivalent)(For Adults)Specification:As per the WHO recommendations the Trivalent vaccines for use in the 2027 influenza season (NH) contain the following: Cell culture-, recombinant protein - or Nucleic Acid based vaccines• an A/Missouri/11/2025 (H1N1) pdm09-like virus;• an A/Darwin/1415/2025 (H3N2)-like virus; and • a B/Pennsylvania/14/2025 (B/Victoria lineage)-like virus. Whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly At least ¾ of the shelf life should be available at the time of delivery.Minimum Shelf Life: 12 Months Please Enable Macros to View BoQ information |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 19 daysBid Opening Date
Technical bids will be opened and evaluated.
Upcoming · 21 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender